期刊文献+

HCV核心抗原N-端片段生物素化表达质粒的构建及表达 被引量:3

Construction and Expression of Biotinylated Expression Vector for Amino Acid Fragment at N-terminus of HCV Core Antigen
原文传递
导出
摘要 目的构建HCV核心(C)抗原N-端1~130aa片段的生物素化表达质粒,并在大肠杆菌中进行表达。方法PCR扩增HCV C抗原N-端1~130aa片段的编码基因,拼接上生物素-蛋白连接酶底物肽序列(BSP),构建重组原核表达质粒pGEX4T-1-CN130BSP,转化大肠杆菌Rosetta,IPTG诱导表达。表达产物经SDS-PAGE后,电转至硝酸纤维素膜上,以抗HCVC抗原的单克隆抗体和辣根过氧化物酶标记的亲和素对表达产物进行分析。结果PCR扩增出约466bp的目的基因片段;质粒pGEX4T-1-CN130BSP经PCR及双酶切鉴定,与预期结果一致,测序鉴定基因无突变;SDS-PAGE显示表达产物相对分子质量约为42000,22℃诱导16h可溶性表达产物含量较高;表达的重组蛋白可被抗HCV C抗原的单克隆抗体所识别,并能特异性结合辣根过氧化物酶标记的亲和素。结论已成功构建了HCV C抗原N-端1~130aa片段生物素化表达质粒,并表达出带生物素标签的GST融合蛋白,为进一步研制HCV双抗原夹心检测试剂奠定了基础。 Objective To construct a biotinylated expression vector for 1 ~ 130 aa fragment at N-terminus of HCV core antigen.Methods The gene encoding 1 ~ 130 aa fragment at N-terminus of HCV core antigen was amplified by PCR and spliced to BirA substrate peptide(BSP)gene sequence.The constructed recombinant prokaryotic expression vector pGEX4T-1-CN130BSP was transformed to E.coli Rosetta for expression under induction of IPTG.The expressed product was identified by SDS-PAGE,then transferred to a nitrocellulose filter and analyzed with McAb against HCV core antigen and HRP-labeled avidin.Results A target gene fragment at length of 466 bp was amplified by PCR.Both PCR and restriction analysis proved that recombinant plasmid pGEX4T-1-CN130BSP was constructed correctly,and sequencing result showed no gene mutation.SDS-PAGE showed expressed protein with a relative molecular mass of about 42 000.After induction at 22℃ for 16 h,the expression level of soluble protein reached a peak value.The expressed product was recognized with McAb against HCV core antigen,and bound to HRP-labeled avidin specifically.Conclusion A biotinylated expression vector for 1 ~ 130 aa fragment at Nterminus of HCV core antigen was successfully constructed,and GST fusion protein with biotin labeling was expressed,which laid a foundation of further preparation of double antigen sandwich detection kit for HCV.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第10期949-952,共4页 Chinese Journal of Biologicals
基金 广东省科技计划项目(2008A030201025) 深圳市科技计划项目(200712) 深圳大学青年基金(200835)
关键词 丙型肝炎病毒 核心抗原 N-端片段 生物素化 原核表达 HCV Core antigen N-terminal fragment Biotinylation Prokaryotic expression
  • 相关文献

参考文献5

二级参考文献43

共引文献48

同被引文献28

  • 1Mohammad Irshad,Dhananjay Singh Mankotia,Khushboo Irshad.An insight into the diagnosis and pathogenesis of hepatitis C virus infection[J].World Journal of Gastroenterology,2013,19(44):7896-7909. 被引量:55
  • 2丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 3谢立,吴晓东.丙型肝炎病毒检测方法的研究进展及其临床意义[J].世界华人消化杂志,2005,13(7):884-886. 被引量:56
  • 4石爽,庄辉.重视丙型肝炎的筛查[J].肝脏,2007,12(5):333-335. 被引量:37
  • 5中华人民共和国卫生部.WS213-2008 丙型病毒性肝炎诊断标准[M]北京:人民卫生出版社,2009.
  • 6中华人民共和国国家质量监督检验检疫总局;中国国家标准化管理委员会.GB/T 21415-2008 体外诊断医疗器械生物样品中量的测量校准品和控制物质赋值的计量学溯源性[M]北京:中国标准出版社,20081-18.
  • 7Callaghan CA, Byford MF, Wyer JR, et al. BirA Enzyme: Production and Application in the Study of Membrane Receptor- Ligand Interactions by Site-Specific Biotinylation Original Research. Analytical Biochemistry, 1999, 266: 9-15. doi: 10. 1006/abio. 1998. 2930.
  • 8Fairhead M, Howarth M. Site-specific biotinylation of purified proteins using BirA. Methods Mol Biol, 2015, 1266: 171-84. doi : 10~ 1007/978-1-4939-2272-7-12.
  • 9Li Y, Sousa R. Expression and purification of E. coli BirA biotin ligase for in vitro biotinylation. Protein Expr Purif, 2012, 82: 162-7. doi: 10. 1016/j. pep. 2011. 12. 008.
  • 10Dorothy B, Elena K, Peter J. Schatz. A minimal peptide substrate in biotin holoenzyme synthetase-eatalyzed biotinylation. Protein Science, 1999, 8:921-929. doi: 10. 1110/ps. 8.4. 921.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部